| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Harmony Biosciences Holdings, Inc.'s insiders have reduced their positions by a net 72,406 shares worth roughly $3.1M.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 24.5K | $907.8K | - | |
| Other | 13.1K | $485.5K | - | |
| CEO | 7.3K | $271.9K | - | |
| Other | 4.3K | $160.2K | - | |
| Other | 1.5K | $54.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 27, 2025 | Jeffrey Dierks62 | Chief Commercial Officer | Sale+OE10b5-1 | 14,754 | $37.38 | $551,575.01 | - | -23.2% | -1.5% | |
| Jan 27, 2025 | Sandip Kapadia71 | Chief Financial Officer | Sale+OE10b5-1 | 1,775 | $38.05 | $67,547.27 | - | -23.2% | -1.5% | |
| Jan 21, 2025 | Sandip Kapadia71 | Chief Financial Officer | Sale+OE10b5-1 | 25,000 | $40.18 | $1,004,597.50 | - | -29.6% | -9.3% | |
| Jan 21, 2025 | Jeffrey M. Dayno54 | President, CEO | Sale+OE10b5-1 | 19,293 | $40.13 | $774,245.45 | - | -29.6% | -9.3% | |
| Jan 21, 2025 | Jeffrey Dierks62 | Chief Commercial Officer | Sale+OE10b5-1 | 30,598 | $37.51 | $1,147,715.34 | - | -29.6% | -9.3% | |
| Jan 15, 2025 | Jeffrey Dierks62 | Chief Commercial Officer | Sale+OE10b5-1 | 10,507 | $37.01 | $388,840.95 | - | -22.2% | -1.4% | |
| Jan 13, 2025 | Jeffrey Dierks62 | Chief Commercial Officer | Sale+OE10b5-1 | 7,180 | $37.04 | $265,946.48 | - | -19.0% | -1.9% | |
| Nov 5, 2024 | Marshman Fund Trust II | 10% Owner | Sell | 4,600,000 | $30.30 | $139,391,500.00 | -43.2% | +15.8% | -6.2% | |
| Nov 5, 2024 | Valor IV Pharma Holdings, LLC | 10% Owner | Sell | 4,600,000 | $30.30 | $139,391,500.00 | -41.0% | +15.8% | -6.2% | |
| Oct 29, 2024 | Jeffrey Dierks62 | Chief Commercial Officer | Sale+OE10b5-1 | 21,496 | $40.47 | $870,018.36 | - | -7.8% | -29.3% |